Priority Date: 19.09.06 (EP 20060384014)

Combination of the NMDA- receptor ligand memantine and a compound with 5-HT6 receptor affinity

  • Application ID: EP07820281
  • Status: No opposition filed within time limit

Applicant

Attorney

Employment test 11 - 50 employees
Company dna abg patentes sl
operating since 2003
1113.35
Headquarter in Madrid and 1 office
active in Legal Services and IP Consulting

Specialization

This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). ABG Patentes SL is specialized in A61. Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 19.09.2006 - Priority Date (EP 20060384014)
  • 27.03.2008 - Publication A1 (WO2008034815)
  • 29.07.2009 - Publication A1 (EP2081600)
  • 05.12.2012 - Publication B1 (EP2081600)